title: Treatment options for localized scleroderma.
abstract: Localized scleroderma, or morphea, is a chronic disease that causes a thickening and induration of the skin. For plaque type morphea, the treatments of choice include super-potent corticosteroids and calcipotriol. For the more generalized forms, as well as the linear forms, UVA is currently the best therapeutic modality. Patients with localized scleroderma are managed by both rheumatologists and dermatologists. There is still much therapeutic uncertainty in this disease.
authors.affiliation: Divisions of Dermatology and Rheumatology, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
authors.forename: J
authors.initials: J
authors.lastname: Dutz
mesh_terms: D003879:Dermatologic Agents / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008297:Male; D011701:PUVA Therapy; D011379:Prognosis; D012594:Scleroderma, Localized / Q000628:therapy*; D014467:Ultraviolet Therapy
chemical_list: D003879:Dermatologic Agents